Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy.
Gregory K, Hansen D, Penglase R, Apostolopoulos D, Ngian GS, Stevens W, Morrisroe K, Ferdowsi N, Ross L, Walker J, Cooley H, Youssef P, Tymms K, Host L, Proudman S, Moore J, Nikpour M, Sahhar J. Gregory K, et al. Among authors: cooley h. Arthritis Rheumatol. 2024 Apr 1. doi: 10.1002/art.42850. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38560777
A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study.
Jee AS, Stewart I, Youssef P, Adelstein S, Lai D, Hua S, Stevens W, Proudman S, Ngian GS, Glaspole IN, Moodley YP, Bleasel JF, Macansh S, Nikpour M, Sahhar J, Corte TJ; Australian Scleroderma Cohort Study, Australian Scleroderma Interest Group, Australian Idiopathic Pulmonary Fibrosis Registry, and associated investigators. Jee AS, et al. Arthritis Rheumatol. 2023 Aug;75(8):1424-1433. doi: 10.1002/art.42491. Epub 2023 May 15. Arthritis Rheumatol. 2023. PMID: 36908055
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL, Hansen D, Ross L, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Apostolopoulous D, Ferdowsi N, Wilson M, Tabesh M, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Fairley JL, et al. Arthritis Res Ther. 2023 May 12;25(1):77. doi: 10.1186/s13075-023-03059-x. Arthritis Res Ther. 2023. PMID: 37173780 Free PMC article.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Deakin CT, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. JAMA Netw Open. 2023. PMID: 37382956 Free PMC article. Clinical Trial.
2023 CCS/CSE Standards for Physician Training and Maintenance of Competence in Adult Echocardiography: Executive Summary.
Nair P, Chen-Tournoux A, Almufleh AS, Blissett S, Ducas R, Fine NM, Johri AM, Kushneriuk D, Ramer S, Sanfilippo A, Thibodeau-Jarry N, Yu E, Bewick D, Burwash IG, Chow CM, Cooley H, De S, Douflé G, Fagan SM, Henri C, Jassal DS, Jelic T, Lee D, Leipsic J, Leong-Poi H, Luksun W, Mulloy AJ, Mulvagh S, Nesbitt G, Promislow S, Sebag IA, Tran DTT, Tsang TSM. Nair P, et al. Among authors: cooley h. Can J Cardiol. 2023 Oct;39(10):1302-1306. doi: 10.1016/j.cjca.2023.06.418. Epub 2023 Jun 22. Can J Cardiol. 2023. PMID: 37355231 Free article. No abstract available.
Occupational silica exposure in an Australian systemic sclerosis cohort.
Patel S, Morrisroe K, Proudman S, Hansen D, Sahhar J, Sim MR, Ngian GS, Walker J, Strickland G, Wilson M, Ferdowsi N, Major G, Roddy J, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Patel S, et al. Rheumatology (Oxford). 2020 Dec 1;59(12):3900-3905. doi: 10.1093/rheumatology/keaa446. Rheumatology (Oxford). 2020. PMID: 32911541
59 results